European PharmaEurope's Biotech Exposure Is Narrow but Real: A Swedish Royalty Stream Grows While the AI Funding Mood SoursVia News Editorial Team•Nov 15, 2026
European BiotechNovo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI PartnerVia News Editorial Team•Jun 25, 2026
European Corporate StrategyLakefront Biotherapeutics Closes Ouro Acquisition, Retains €2B War Chest for Further DealsVia News Editorial Team•Jun 7, 2026